RT Journal Article
SR Electronic
T1 Clinical implementation of a machine learning system to detect deteriorating patients reduces time to response and intervention
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.10.21264823
DO 10.1101/2021.10.10.21264823
A1 Brufau, Santiago Romero
A1 Rosenthal, Jacob
A1 Kautz, Jordan
A1 Storlie, Curtis
A1 Gaines, Kim
A1 Nagel, Jill
A1 VanDeusen, Adam
A1 Johnson, Matthew
A1 Hickman, Joel
A1 Hardin, Dale
A1 Schmidt, Julie
A1 Dankbar, Gene
A1 Huddleston, Jeanne
YR 2021
UL http://medrxiv.org/content/early/2021/10/12/2021.10.10.21264823.abstract
AB Introduction Acute physiological deterioration is a major contributor to in-hospital morbidity and mortality. Early detection and intervention of deteriorating patients is key to improving patient outcomes. Prior research has demonstrated the effectiveness of Early Warning Systems and other algorithmic approaches in automatically identifying these patients from passively monitoring vital signs.Methods In this work, we conduct a prospective pilot study of clinical deployment of the Mayo Clinic Bedside Patient Rescue (BPR) system using an escalating alerting logic enabled by machine learning. Among four units where the BPR system was deployed, time to response and time to intervention for deteriorating patients were significantly reduced relative to matched control units.Results In pilot units, time to response decreased by 35.4% (from 63.2 minutes to 40.8 minutes) and time to intervention decreased by 48.5% (from 106.3 minutes to 55.9 minutes). No significant differences were observed in counterbalance metrics of mortality, ICU transfer rate, and Rapid Response Team activation rate. Furthermore, the automated alerting system was well-received by clinicians participating in the pilot study, as assessed by survey.Discussion These results demonstrate a successful clinical deployment of a practice-changing machine learning alert system with demonstrable impact on improving patient care.Competing Interest StatementThe BPR model was licensed by Mayo Clinic to a third-party company; some authors receive royalties as part of the agreement.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Mayo Clinic Institutional Review Board waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData produced in the present study are available upon reasonable request to the authors.